Peroxisome Proliferator-Activated Receptor-γ Pro12Ala Polymorphism and Risk of Osteopenia in β-Thalassemia Major Patients

REFERENCES

• Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with β thalassaemia. Br J Haematol. 2004;127(2):127–139.
   PubMed Web of Science ®Google Scholar
• Giguere Y, Rousseau F. The genetics of osteoporosis: ‘complexities and difficulties’. Clin Genet. 2000;57(3):161–169.
   PubMed Web of Science ®Google Scholar
• Origa R, Fiumana E, Gamberini MR, Osteoporosis in β-thalassemia: clinical and genetic aspects. Ann NY Acad Sci. 2005;1054:451–456.
   Google Scholar
• Vogiatzi MG, Autio KA, Schneider R, Giardina PJV. Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab. 2004;17(10):1415–1421.
   PubMedGoogle Scholar
• Rhee EJ, Oh KW, Yun EJ, The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ gene with serum osteoprotegerin levels in healthy Korean women. Exp Mol Med. 2007;39(6):696–704.
   PubMedGoogle Scholar
• Jensen CE, Tuck SM, Agnew JE, High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab. 1998;3(Suppl 1):975–977.
   Google Scholar
• Guzeloglu-Kayisli O, Cetin Z, Keser I, Relationship between SP1 polymorphism and osteoporosis in β-thalassemia major patients. Pediatr Int. 2008;50(4):474–476.
   PubMedGoogle Scholar
• Chinetti-Gbaguidi G, Fruchart JC, Staels B. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy. Curr Opin Pharmacol. 2005;5(2):177–183.
   PubMedGoogle Scholar
• Fournier T, Handschuh K, Tsatsaris V, Evain-Brion D. Involvement of PPARγ in human trophoblast invasion. Placenta. 2007;28(Suppl A):S76–S81.
   Google Scholar
• Minge CE, Robker RL, Norman RJ. PPARγ: coordinating metabolic and immune contributions to female fertility. PPAR Res. 2008;2008:243791. doi: 10.1155/2008/243791.:243791
   Google Scholar
• Chan BY, Gartland A, Wilson PJM, PPAR agonists modulate human osteoclast formation and activity in vitro. Bone. 2007;40(1):149–159.
   PubMedGoogle Scholar
• Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor-γ 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology. 2002;143(6):2376–2384.
   PubMed Web of Science ®Google Scholar
• Rees WD, McNeil CJ, Maloney CA. The roles of PPARs in the fetal origins of metabolic health and disease. PPAR Res. 2008;2008:459030. doi: 10.1155/2008/459030.:459030.
   PubMedGoogle Scholar
• Soroceanu MA, Miao D, Bai XY, Su H, Goltzman D, Karaplis AC. Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. J Endocrinol. 2004;183(1):203–216.
   PubMed Web of Science ®Google Scholar
• Mbalaviele G, Abu-Amer Y, Meng A, Activation of peroxisome proliferator-activated receptor-γ pathway inhibits osteoclast differentiation. J Biol Chem. 2000;275(19):14388–14393.
   PubMed Web of Science ®Google Scholar
• Yue H, He JW, Zhang H, No association between polymorphisms of peroxisome [corrected] proliferator-activated receptor-γ gene and peak bone mineral density variation in Chinese nuclear families. Osteoporos Int. 2010;21(5):873–882.
   PubMedGoogle Scholar
• Rhee EJ, Oh KW, Lee WY, The effects of C161>T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-γ gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. Am J Obstet Gynecol. 2005;192(4):1087–1093.
   PubMedGoogle Scholar
• Sahmani M, Sakhinia E, Farzadi L, Two common polymorphisms in the peroxisome proliferator-activated receptor γ gene may improve fertilization in IVF. Reprod Biomed Online. 2011;23(3):355–360.
   PubMedGoogle Scholar
• Ebrahimpour L, Akhlaghpoor S, Azarkeivan A, Salehi M, Morteza A, Alinaghi R. Correlation between bone mineral densitometry and liver/heart iron overload evaluated by quantitative T2* MRI. Hematology. 2012;17(5):297–301.
   PubMed Web of Science ®Google Scholar
• Lo L, Singer ST. Thalassemia: current approach to an old disease. Pediatr Clin North Am. 2002;49(6):1165–1191.
   PubMedGoogle Scholar
• El-Edel RH, Ghonaim MM, Abo-Salem OM, El-Nemr FM. Bone mineral density and vitamin D receptor polymorphism in β-thalassemia major. Pak J Pharm Sci. 2010;23(1):89–96.
   PubMedGoogle Scholar
• Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with β-thalassaemia major and intermedia. Br J Haematol. 2000;111(3):902–907.
   PubMed Web of Science ®Google Scholar
• Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999;20(5):649–688.
   PubMed Web of Science ®Google Scholar
• Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology. 1999;140(4):1630–1638.
   PubMed Web of Science ®Google Scholar
• Akune T, Ohba S, Kamekura S, PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest. 2004;113(6):846–855.
   PubMed Web of Science ®Google Scholar
• Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res. 1998;13(3):371–382.
   PubMed Web of Science ®Google Scholar
• Woo KM, Choi Y, Ko SH, Ko JS, Oh KO, Kim KK. Osteoprotegerin is present on the membrane of osteoclasts isolated from mouse long bones. Exp Mol Med. 2002;34(5):347–352.
   PubMedGoogle Scholar
• Okazaki R, Toriumi M, Fukumoto S, Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Endocrinology. 1999;140(11):5060–5065.
   PubMedGoogle Scholar
• Masud S, Ye S. Effect of the peroxisome proliferator activated receptor-γ gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet. 2003;40(10):773–780.
   PubMedGoogle Scholar